SecBot SecBot
SECBOTREPLAY Home › Report › ABCL

ABCL · Insider buys $796K post-Q3

AbCellera Biologics Inc. · CLUSTER filed Nov 13, 2026 at 12:41 ET

At the news

BULLISHIMPACT 4/10

CLUSTER filed Nov 13, 2026 at 12:41 ET

Two insiders at AbCellera, including the CFO and a 10% owner, made open-market purchases totaling $796K in the week following Q3 earnings that showed 19% revenue growth and a narrower net loss. The CFO's $97K buy and the 10% owner's $699K buy, both outside 10b5-1 plans, signal insider confidence after positive Phase 2 data and a completed $200M equity offering.

  • CFO Andrew Booth purchased 8,600 shares at $11.33 for $97K on 2026-11-13 (no 10b5-1 plan)
  • 10% owner Thermopylae Holdings purchased 60,565 shares at $11.54 for $699K on 2026-11-12 (no 10b5-1 plan)
  • Total open-market purchases: $796K
  • Q3 2026 revenue $10.6M (+19% YoY), net loss narrowed to $40.8M from $57.1M

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access